Cargando…

Pediatric Invasive Pneumococcal Disease Three Years after PCV13 Introduction in the National Immunization Plan—The Continued Importance of Serotype 3

The introduction of pneumococcal conjugate vaccines PCV7 and PCV13 led to decreases in incidence of pediatric invasive pneumococcal disease (pIPD) and changes in serotype distribution. We evaluated the consequences of higher vaccine uptake after the introduction of PCV13 in the National Immunization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva-Costa, Catarina, Gomes-Silva, Joana, Prados, Lúcia, Ramirez, Mário, Melo-Cristino, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304318/ https://www.ncbi.nlm.nih.gov/pubmed/34361864 http://dx.doi.org/10.3390/microorganisms9071428

Ejemplares similares

1452. Non-invasive Pneumococcal Pneumonia in Adults in Portugal: Continued Decline of PCV13 Serotypes (2015–2017)
por: Silva-Costa, Catarina, et al.
Publicado: (2018)

Invasive Pneumococcal Disease in Adults in Portugal: The Importance of Serotypes 8 and 3 (2015–2018)
por: Silva-Costa, Catarina, et al.
Publicado: (2021)

Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012–2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes
por: Horácio, Andreia N., et al.
Publicado: (2016)

Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi
por: Kirolos, Amir, et al.
Publicado: (2023)

Noninvasive Pneumococcal Pneumonia in Adults in Portugal (2012–2015): Resilience of Vaccine Serotypes and Emergence of Non-vaccine Serotypes
por: Horácio, Andreia N, et al.
Publicado: (2017)

Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)
por: Silva-Costa, Catarina, et al.
Publicado: (2019)

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
por: Gladstone, Rebecca A., et al.
Publicado: (2015)

Continued Vaccine Breakthrough Cases of Serotype 3 Complicated Pneumonia in Vaccinated Children, Portugal (2016–2019)
por: Silva-Costa, Catarina, et al.
Publicado: (2022)

1443. Serotypes 8 and 3 Are the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2015–2017)
por: Silva-Costa, Catarina, et al.
Publicado: (2018)

Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
por: Bennett, Julia C., et al.
Publicado: (2021)

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
por: Izquierdo, C., et al.
Publicado: (2020)

Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015)
por: Horácio, Andreia N., et al.
Publicado: (2018)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
por: Silva-Costa, Catarina, et al.
Publicado: (2018)

2703. Pneumococcal Carriage of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Non-PCV13 Serotypes among Greek Children Vaccinated with PCV13 in a 3 + 1 Schedule During the First 6 years after the Fourth Dose of PCV13
por: Syrogiannopoulos, George A, et al.
Publicado: (2019)

Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011
por: Horácio, Andreia N., et al.
Publicado: (2016)

Non-Invasive Pneumococcal Pneumonia in Portugal—Serotype Distribution and Antimicrobial Resistance
por: Horácio, Andreia N., et al.
Publicado: (2014)

Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan
por: Nisar, Muhammad Imran, et al.
Publicado: (2022)

The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination
por: Slotved, Hans-Christian, et al.
Publicado: (2016)

Impact of PCV13 on Serotype 3 Invasive Pneumococcal Disease and Nasopharyngeal Carriage in Massachusetts’ Children
por: Lapidot, Rotem, et al.
Publicado: (2017)

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

1180. Comparing Changes in Pneumococcal Meningitis Incidence to all Invasive Pneumococcal Disease Following Introduction of PCV10 and PCV13: The PSERENADE Project
por: Yang, Yangyupei, et al.
Publicado: (2021)

Population genomics of pneumococcal carriage in Massachusetts children following introduction of PCV-13
por: Mitchell, Patrick K., et al.
Publicado: (2019)

Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization
por: Javaid, Nida, et al.
Publicado: (2022)

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
por: Deloria Knoll, Maria, et al.
Publicado: (2021)

Characteristics of Serotype 3 Invasive Pneumococcal Disease before and after Universal Childhood Immunization with PCV13 in Massachusetts
por: Lapidot, Rotem, et al.
Publicado: (2020)

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
por: Garcia Quesada, Maria, et al.
Publicado: (2021)

Changing Epidemiology of Invasive Pneumococcal Disease due to Conjugate Vaccine Serotypes in Toronto, Canada After Introduction of a Routine Pediatric PCV13 Program
por: Mcgeer, Allison, et al.
Publicado: (2017)

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
por: Galanis, Ilias, et al.
Publicado: (2016)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

1429. Emergence of Multidrug-resistant Serotype 24 Among Children Under 2 Years Old With Invasive Pneumococcal Disease After the Introduction of PCV13 in Argentina
por: Gagetti, Paula, et al.
Publicado: (2018)

Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
por: Ludwig, Guillermo, et al.
Publicado: (2020)

2716. Persistence of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Serotypes in Invasive Pneumococcal Disease in Adults in Southern Ontario Canada Despite Routine Pediatric Vaccination
por: McGeer, Allison, et al.
Publicado: (2019)

1468. PCV13 Serotype Trends Over Time in Pneumococcal Community Acquired Pneumonia: Which Method(s) Work Best?
por: Leblanc, Jason, et al.
Publicado: (2018)

Molecular Characterization and Antibiotic Susceptibility of Non-PCV13 Pneumococcal Serotypes among Vaccinated Children in Cape Coast, Ghana
por: Mills, Richael O., et al.
Publicado: (2022)

1173. Changes in Invasive Pneumococcal Disease Incidence Following Introduction of PCV10 and PCV13 Among Children < 5 Years: The PSERENADE Project
por: Bennett, Julia C, et al.
Publicado: (2021)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine
por: Patel, Sweta M., et al.
Publicado: (2022)

Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain
por: Morales, María, et al.
Publicado: (2018)

Genomic Characteristics of Invasive Streptococcus pneumoniae Serotype 1 in New Caledonia Prior to the Introduction of PCV13
por: Hanachi, Mariem, et al.
Publicado: (2020)

Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced
por: Chang, Qiuzhi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q55ph9814oh131gho2t5u4hmhp